These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 581903)

  • 21. [Hypothyroidism following 131 I therapy of Basedow's disease].
    Mori T; Konishi J; Ikekubo K; Endo K; Morita R
    Nihon Rinsho; 1974 Jul; 32(7):2381-6. PubMed ID: 4479877
    [No Abstract]   [Full Text] [Related]  

  • 22. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA; Daykin J; Holder R; Sheppard MC
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hyperthyreosis in Basedow's disease].
    Välimäki MJ
    Duodecim; 1998; 114(5):447-54. PubMed ID: 11466937
    [No Abstract]   [Full Text] [Related]  

  • 24. [131I therapy in hyperthyroidism. Results of treatment from 1960-1974].
    Heinze HG; Schenk F
    Nuklearmedizin; 1977 Feb; 16(1):1-12. PubMed ID: 846862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [131I-therapy of Basedow's disease and nonimmunogenic hyperthyroidism].
    Hoeschel M; Heinze HG
    Nuklearmedizin; 1984 Jun; 23(3):143-9. PubMed ID: 6548309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Combination of low doses of iodine 131 and synthetic antithyroid drugs in long-term care of Basedow's disease. Its value in the prevention of secondary hypothyroidism. (Apropos of 165 cases)].
    Jaffiol C; Baldet L; Ghachem M; Robin M; Mirouze J
    Sem Hop; 1973 Feb; 49(10):683-92. PubMed ID: 4122346
    [No Abstract]   [Full Text] [Related]  

  • 27. [Determination of factors affecting the therapeutic outcome of radioiodine therapy in patients with Graves' disease].
    Sabri O; Schulz G; Zimny M; Schreckenberger M; Zimny D; Wagenknecht G; Kaiser HJ; Dohmen BM; Bares R; Büll U
    Nuklearmedizin; 1998 May; 37(3):83-9. PubMed ID: 9604227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Undetected latrogenic hypothyroidism: a late complication of radio-iodine therapy.
    Smidt KP; Johnston E
    N Z Med J; 1975 Apr; 81(537):325-8. PubMed ID: 1056550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal iodine-131 dose for eliminating hyperthyroidism in Graves' disease.
    Nordyke RA; Gilbert FI
    J Nucl Med; 1991 Mar; 32(3):411-6. PubMed ID: 2005449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lat e results of the radioactive iodine treatments of toxic goiter].
    Kurbatova LI
    Klin Med (Mosk); 1975 May; 52(5):46-50. PubMed ID: 1173451
    [No Abstract]   [Full Text] [Related]  

  • 31. Radioiodine-induced hypothyroidism in Graves' disease: factors associated.
    Cunnien AJ; Hay ID; Gorman CA; Offord KP; Scanlon PW
    J Nucl Med; 1982 Nov; 23(11):978-83. PubMed ID: 6897075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Surgical treatment of Basedow's disease. Short- and long-term results in a caseload of 102 interventions].
    Palestini N; Carena F; Carlin R; Valori MR
    Ann Ital Chir; 1983; 55(1):1-9. PubMed ID: 6689113
    [No Abstract]   [Full Text] [Related]  

  • 33. What influences early hypothyroidism after radioiodine treatment for Graves' hyperthyroidism?
    Vijayakumar V; Ali S; Nishino T; Nusynowitz M
    Clin Nucl Med; 2006 Nov; 31(11):688-9. PubMed ID: 17053385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early results of 125I therapy of thyrotoxic Graves' disease.
    Siemsen JK; Wallack MS; Martin RB; Nicoloff JT
    J Nucl Med; 1974 Apr; 15(4):257-60. PubMed ID: 4406129
    [No Abstract]   [Full Text] [Related]  

  • 35. [Volume reduction of the thyroid after radioiodine therapy in patients with autonomous goiter and Basedow's goiter].
    Dederichs B; Otte R; Klink JE; Schicha H
    Nuklearmedizin; 1996 Oct; 35(5):164-9. PubMed ID: 9005412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The treatment of Basedow's disease in early pregnancy with iodine radioisotopes].
    Gavallér I
    Orv Hetil; 1974 May; 115(20):1169-71. PubMed ID: 4406530
    [No Abstract]   [Full Text] [Related]  

  • 37. [Possible sequelae of the action of radioactive iodine in man].
    Il'in LA; Arkhangel'skaia GV
    Med Radiol (Mosk); 1973 Aug; 18(8):66-80. PubMed ID: 4801844
    [No Abstract]   [Full Text] [Related]  

  • 38. [Short-term course of Graves-Basedow disease treated with I131. Prevalence of transient hypothyroidism].
    Virgili N; Gómez JM; Montaña E; Soler J; Castells M; Roca M
    Rev Clin Esp; 1988 Oct; 183(6):300-3. PubMed ID: 3217548
    [No Abstract]   [Full Text] [Related]  

  • 39. [131-I treatment of Basedow's disease].
    Hara M
    Horumon To Rinsho; 1974 Feb; 22(2):263-8. PubMed ID: 4407981
    [No Abstract]   [Full Text] [Related]  

  • 40. Radioiodine therapy in thyrotoxicosis.
    Taher MA; Loken MK; Bantle JP
    J Indian Med Assoc; 1991 Apr; 89(4):86-8. PubMed ID: 1940400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.